Scientific Publications
Tsagkas C; Parmar K; Pezold S; Barro C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Papadopoulou A; Wuerfel J; Kappos L; Kuhle J; Sprenger T; Granziera C; Magon S.
Classification of multiple sclerosis based on patterns of CNSregional atrophy covariance.
Human brain mapping. 2021.
Papadopoulou A; Oertel FC; Chien C; Kuchling J; Zimmermann HG; Siebert N; Motamedi S; Souza M; Asseyer S; Bellmann-Strobl J; Ruprecht K; Chakravarty MM; Scheel M; Magon S; Wuerfel J; Paul F; Brandt AU.
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study.
NeuroImage. Clinical. 2021.
D'Souza M; Papadopoulou A; Girardey C; Kappos L.
Standardization and digitization of clinical data in multiple sclerosis.
Nature reviews. Neurology. 2021.
Derfuss T; Mehling M; Papadopoulou A; Bar-Or A; Cohen JA; Kappos L.
Advances in oral immunomodulating therapies in relapsing multiple sclerosis.
The Lancet. Neurology. 2020.
D'Souza M; Papadopoulou A; Levy M; Jacob A; Yeaman MR; Kümpfel T; Marignier R; Paul F; Brandt AU.
Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international survey.
Multiple sclerosis and related disorders. 2020.
Zuber P; Tsagkas C; Papadopoulou A; Gaetano L; Huerbin M; Geiter E; Altermatt A; Parmar K; Ettlin T; Schuster-Amft C; Suica Z; Alrasheed H; Wuerfel J; Kesselring J; Kappos L; Sprenger T; Magon S.
Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.
Journal of neurology. 2020.
D'Souza M; Heikkilä A; Lorscheider J; Haller V; Kravalis K; Gysin S; Fuertes NAC; Fricker E; Lam E; Higgins P; Tomic D; Papadopoulou A; Kappos L.
Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.
Multiple sclerosis (Houndmills, Basingstoke, England). 2020.
Gkaniatsou T; Papadopoulou A; Paul F; Brandt AU; Oertel FC.
Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.
ACTA NEUROLOGICA BELGICA. 2020.
Kronlage C; Papadopoulou A; De Marchis GM.
Isolated oculomotor palsy due to acute ischemic midbrain stroke.
ACTA NEUROLOGICA BELGICA. 2020.
Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S.
Longitudinal patterns of cortical thinning in multiple sclerosis.
Human brain mapping. 2020.
Juenger V; Cooper G; Chien C; Chikermane M; Oertel FC; Zimmermann H; Ruprecht K; Jarius S; Siebert N; Kuchling J; Papadopoulou A; Asseyer S; Bellmann-Strobl J; Paul F; Brandt AU; Scheel M.
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
European radiology. 2020.
Magon S.; Pfister A.; Laura G.; Luthi M.; Papadopoulou A.; Kappos L.; Sprenger T..
Short timescale modulation of cortical and cerebellar activity in the early phase of motor sequence learning: an fMRI study.
Brain Imaging and Behavior. 2020.
Asseyer S; Kuchling J; Gaetano L; Komnenić D; Siebert N; Chien C; Scheel M; Oertel FC; Ruprecht K; Bellmann-Strobl J; Finke C; Chakravarty MM; Magon S; Wuerfel J; Paul F; Papadopoulou A; Brandt AU.
Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Multiple sclerosis and related disorders. 2020.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T.
Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Journal of neurology. 2020.
Papadopoulou A; Gaetano L; Pfister A; Altermatt A; Tsagkas C; Morency F; Brandt AU; Hardmeier M; Chakravarty MM; Descoteaux M; Kappos L; Sprenger T; Magon S.
Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
Neurology. 2019.
Papadopoulou A; Oertel FC; Gaetano L; Kuchling J; Zimmermann H; Chien C; Siebert N; Asseyer S; Bellmann-Strobl J; Ruprecht K; Chakravarty MM; Scheel M; Magon S; Wuerfel J; Paul F; Brandt AU.
Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Journal of neurology, neurosurgery, and psychiatry. 2019.
Nolan-Kenney RC; Liu M; Akhand O; Calabresi PA; Paul F; Petzold A; Balk L; Brandt AU; Martínez-Lapiscina EH; Saidha S; Villoslada P; Al-Hassan AA; Behbehani R; Frohman EM; Frohman T; Havla J; Hemmer B; Jiang H; Knier B; Korn T; Leocani L; Papadopoulou A; Pisa M; Zimmermann H; Galetta SL; Balcer LJ; International Multiple Sclerosis Visual System Consortium.
Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.
Annals of neurology. 2019.
Papadopoulou A; Oertel FC; Zimmermann H; Zeitz O; Brandt AU; Paul F.
[Optical Coherence Tomography in Disorders of the Central Nervous System].
Klinische Monatsblatter fur Augenheilkunde. 2018.
Seifert CL; Schönbach EM; Zimmer C; Förschler A; Tölle TR; Feurer R; Gempt J; Papadopoulou A; Magon S; Sprenger T; Poppert H.
Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.
CEPHALALGIA. 2018.
Magon S; Sprenger T; Otti A; Papadopoulou A; Gündel H; Noll-Hussong M.
Cortical Thickness Alterations in Chronic Pain Disorder: An Exploratory MRI Study.
PSYCHOSOMATIC MEDICINE. 2018.
Hanssen H; Minghetti A; Magon S; Rossmeissl A; Rasenack M; Papadopoulou A; Klenk C; Faude O; Zahner L; Sprenger T; Donath L.
Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial.
Scandinavian journal of medicine & science in sports. 2018.
Papadopoulou A; Kronlage C; Kampmann M; Budweg J.
Unilateral leg oedema due to spontaneous Achilles tendon rupture.
Oxford medical case reports. 2018.
Papadopoulou A; Derfuss T; Sprenger T.
Daclizumab for the treatment of multiple sclerosis.
Neurodegenerative disease management. 2017.
D'Souza M; Yaldizli Ö; John R; Vogt DR; Papadopoulou A; Lucassen E; Menegola M; Andelova M; Dahlke F; Schnyder F; Kappos L.
Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.
Multiple sclerosis (Houndmills, Basingstoke, England). 2017.
Hanssen H; Minghetti A; Magon S; Rossmeissl A; Papadopoulou A; Klenk C; Schmidt-Trucksäss A; Faude O; Zahner L; Sprenger T; Donath L.
Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial.
Frontiers in Physiology. 2017.
Andermatt S; Papadopoulou A; Radue EW; Sprenger T; Cattin P.
Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.
JOURNAL OF NEUROIMAGING. 2017.
Papadopoulou A; Ahlhelm FJ; Lyrer P; Kuhle J.
Decision for intravenous thrombolysis in a young patient with acute vertical gaze palsy.
ACTA NEUROLOGICA BELGICA. 2015.
Amann M; Papadopoulou A; Andelova M; Magon S; Mueller-Lenke N; Naegelin Y; Stippich C; Radue EW; Bieri O; Kappos L; Sprenger T.
Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.
Journal of neurology. 2015.
Papadopoulou A; Kappos L; Sprenger T.
Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.
Expert Opinion On Drug Safety. 2015.
Papadopoulou A; Ahlhelm FJ; Sprenger T.
Intrathecal gadolinium for magnetic resonance myelography in spontaneous intracranial hypotension: valuable but may be risky--reply.
JAMA neurology. 2014.
Papadopoulou A; Menegola M; Kuhle J; Ramagopalan SV; D'Souza M; Sprenger T; Radue EW; Kappos L; Yaldizli Ö.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England). 2014.
Papadopoulou A; Naegelin Y; Weier K; Amann M; Hirsch J; von Felten S; Yaldizli O; Sprenger T; Radue EW; Kappos L; Gass A.
MRI characteristics of periaqueductal lesions in multiple sclerosis.
Multiple sclerosis and related disorders. 2014.
Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England). 2014.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England). 2013.
Papadopoulou A; Ahlhelm FJ; Ulmer S; Kappos L; Sprenger T.
Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography.
JAMA neurology. 2013.
Papadopoulou A; von Felten S; Traud S; Rahman A; Quan J; King R; Garren H; Steinman L; Cutter G; Kappos L; Radue EW.
Evolution of MS lesions to black holes under DNA vaccine treatment.
Journal of neurology. 2012.
Papadopoulou A; Kappos L; Sprenger T.
Teriflunomide for oral therapy in multiple sclerosis.
Expert Review of Clinical Pharmacology. 2012.
Yaldizli Ö; Glassl S; Sturm D; Papadopoulou A; Gass A; Tettenborn B; Putzki N.
Fatigue and progression of corpus callosum atrophy in multiple sclerosis.
Journal of neurology. 2011.
Papadopoulou A; D'Souza M; Kappos L; Yaldizli O.
Dimethyl fumarate for multiple sclerosis.
EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2010.
Radue EW; Stuart WH; Calabresi PA; Confavreux C; Galetta SL; Rudick RA; Lublin FD; Weinstock-Guttman B; Wynn DR; Fisher E; Papadopoulou A; Lynn F; Panzara MA; Sandrock AW; SENTINEL Investigators.
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Journal of the neurological sciences. 2010.